The place of sulfonylureas in the therapy for type 2 diabetes mellitusDEL PRATO, Stefano; PULIZZI, Nicolo.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, issn 0026-0495, S20-S27, SUP1Conference Paper

Sulfonylureas in the therapy of type 2 diabetes: where do we stand today?: Proceedings of a symposium held on the occasion of the 41st Annual Meeting of the European Association for the Study of Diabetes, September 11, 2005DEL PRATO, Stefano.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, issn 0026-0495, 29 p., SUP1Conference Proceedings

Proceedings of the 4th World Congress on Controversies to Consensus in Diabetes Obesity and Hypertension (CODHy)RAZ, Itamar; DEL PRATO, Stefano.Diabetes care. 2013, Vol 36, issn 0149-5992, 233 p., SUP2Conference Proceedings

Proceedings of the 3rd World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)RAZ, Itamar; DEL PRATO, Stefano.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, 287 p.Serial Issue

Effects of gliclazide beyond metabolic controlCERIELLO, Antonio.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, issn 0026-0495, S10-S15, SUP1Conference Paper

The importance of first-phase insulin secretion : implications for the therapy of type 2 diabetes mellitusDEL PRATO, Stefano; TIENGO, Antonio.Diabetes/metabolism research and reviews (Print). 2001, Vol 17, Num 3, pp 164-174, issn 1520-7552Article

Multidrug Treatment of Type 2 Diabetes: A challenge for complianceMICCOLI, Roberto; PENNO, Giuseppe; DEL PRATO, Stefano et al.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S231-S235Article

Insulin as an Early Treatment for Type 2 Diabetes: ORIGIN or end of an old question?DEL PRATO, Stefano; DARDANO, Angela; BIANCHI, Cristina et al.Diabetes care. 2013, Vol 36, issn 0149-5992, S198-S204, SUP2Conference Paper

Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of HypertensionGROSSMAN, Ehud.Diabetes care. 2013, Vol 36, issn 0149-5992, S307-S311, SUP2Conference Paper

Glycemic Control Impact on Body Weight Potential to Reduce Cardiovascular Risk: Glucagon-like peptide 1 agonistsSESTI, Giorgio.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S272-S275Article

Bariatric Surgery for Type 2 Diabetes Reversal: The RisksKEIDAR, Andrei.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S361-S366Article

Long-term efficacy of sulfonylureas : a United Kingdom prospective diabetes study perspectiveHOLMAN, Rury R.Metabolism, clinical and experimental. 2006, Vol 55, Num 5, issn 0026-0495, S2-5S, SUP1Conference Paper

Activation of GPR40 as a Therapeutic Target for the Treatment of Type 2 DiabetesBURANT, Charles F.Diabetes care. 2013, Vol 36, issn 0149-5992, S175-S179, SUP2Conference Paper

Heart in Diabetes: A Microvascular DiseaseLAAKSO, Markku.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S145-S149Article

Comparative Efficiency and Safety of Pharmacological Approaches to the Management of ObesityHAINER, Vojtech.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S349-S354Article

Guideline Approach to Therapy in Patients With Newly Diagnosed Type 2 DiabetesRAZ, Itamar.Diabetes care. 2013, Vol 36, issn 0149-5992, S139-S144, SUP2Conference Paper

The Case for: Hypoglycemia Is of Cardiovascular ImportanceLALIC, Nebojsa M.Diabetes care. 2013, Vol 36, issn 0149-5992, S264-S266, SUP2Conference Paper

Insulin: Potential Negative Consequences of Early Routine Use in Patients With Type 2 DiabetesLEBOVITZ, Harold E.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S225-S230Article

Incretin Effects on β-Cell Function, Replication, and Mass: The human perspectiveGARBER, Alan J.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S258-S263Article

Myocardial, Perivascular, and Epicardial FatIOZZO, Patricia.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S371-S379Article

Diabetes and Cardiovascular Disease: When it comes to lipids, statins are all you needBITZUR, Rafael.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S380-S382Article

Changing the Treatment Paradigm for Type 2 DiabetesDEL PRATO, Stefano; PENNO, Giuseppe; MICCOLI, Roberto et al.Diabetes care. 2009, Vol 32, Num 3, pp 5217-5222, issn 0149-5992, 6 p., SUPConference Paper

The ACCORD (Action to Control Cardiovascular Risk in Diabetes) Lipid Trial: What we learn from subgroup analysesGINSBERG, Henry N.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S107-S108Article

Sibutramine on Cardiovascular OutcomeSCHEEN, André J.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S114-S119Article

Childhood Metabolic Syndrome: Must we define it to deal with it?WEISS, Ram.Diabetes care. Supplement. 2011, Vol 34, Num 2, issn 1064-9131, S171-S176Article